CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balances (in shares) at Dec. 31, 2022		48,320,000
Balances at Dec. 31, 2022	$ 225,725	$ 5	$ 545,321	$ (319,601)
Increase (Decrease) in Stockholders' Equity
Induced exchange of convertible notes (in shares)		6,990,000
Induced exchange of convertible notes	26,699		26,699
Common stock issuance and other impacts of the vesting and settlement of equity awards (in shares)		352,000
Common stock issuance and other impacts of the vesting and settlement of equity awards	(722)		(722)
Stock-based compensation	2,446		2,446
Net (loss) income	(3,484)			(3,484)
Comprehensive income (loss)	(3,484)			(3,484)
Balances (in shares) at Mar. 31, 2023		55,662,000
Balances at Mar. 31, 2023	$ 250,664	$ 5	573,744	(323,085)
Balances (in shares) at Dec. 31, 2023	94,668,523	94,669,000
Balances at Dec. 31, 2023	$ 138,003	$ 9	789,537	(651,543)
Increase (Decrease) in Stockholders' Equity
Common stock issuance and other impacts of the vesting and settlement of equity awards (in shares)		446,000
Common stock issuance and other impacts of the vesting and settlement of equity awards	(206)		(206)
Stock-based compensation	1,207		1,207
Net (loss) income	(4,510)			(4,510)
Comprehensive income (loss)	$ (4,510)			(4,510)
Balances (in shares) at Mar. 31, 2024	95,115,452	95,115,000
Balances at Mar. 31, 2024	$ 134,494	$ 9	$ 790,538	$ (656,053)